Profile
Sector:
HealthcareCountry:
United StatesIPO:
11 August 2009Website:
http://www.cumberlandpharma.comNext earnings report:
15 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 20:00:12 GMTDividend
Analysts recommendations
Institutional Ownership
CPIX Latest News
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, will announce its first quarter 2024 financial results and company update after the market closes on Tuesday, May 7, 2024.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Chairman and Chief Executive Officer Todd Anthony - Vice President, Organizational Development John Hamm - Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to Cumberland Pharmaceuticals 2023 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Molly Aggas - Account Supervisor, Dalton Agency A. J. Kazimi - Chairman and Chief Executive Officer Todd Anthony - Vice President, Organizational Development John Hamm - Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to Cumberland Pharmaceuticals Third Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Molly Aggas - IR A.J. Kazimi - CEO Todd Anthony - VP, Organizational Development John Hamm - CFO Conference Call Participants Operator Good afternoon, and welcome to the Cumberland Pharmaceuticals' Second Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Julia Motis - Senior Account Manager, Dalton Agency A.J. Kazimi - CEO Todd Anthony - VP, Organizational Development John Hamm - CFO Operator Good afternoon, and welcome to Cumberland Pharmaceuticals First Quarter 2023 Company Update and Financial Report.
What type of business is Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
What sector is Cumberland Pharmaceuticals in?
Cumberland Pharmaceuticals is in the Healthcare sector
What industry is Cumberland Pharmaceuticals in?
Cumberland Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry
What country is Cumberland Pharmaceuticals from?
Cumberland Pharmaceuticals is headquartered in United States
When did Cumberland Pharmaceuticals go public?
Cumberland Pharmaceuticals initial public offering (IPO) was on 11 August 2009
What is Cumberland Pharmaceuticals website?
https://www.cumberlandpharma.com
Is Cumberland Pharmaceuticals in the S&P 500?
No, Cumberland Pharmaceuticals is not included in the S&P 500 index
Is Cumberland Pharmaceuticals in the NASDAQ 100?
No, Cumberland Pharmaceuticals is not included in the NASDAQ 100 index
Is Cumberland Pharmaceuticals in the Dow Jones?
No, Cumberland Pharmaceuticals is not included in the Dow Jones index
When does Cumberland Pharmaceuticals report earnings?
The next expected earnings date for Cumberland Pharmaceuticals is 15 August 2024